Toggle Search Menu

Chemours News

Showing 31-40 of 463 results
Press Release

The Chemours Company Reports Fourth Quarter and Full Year 2023 Results

The Chemours Company (“Chemours” or “the Company”) (NYSE: CC), a global chemistry company with leading market positions in Titanium Technologies (“TT”), Thermal & Specialized Solutions (“TSS”), and Advanced Performance Materials (“APM”), today announced its financial results for the fourth quarter and full year 2023.

Read More Press Release

Chemours Announces Dates for Fourth Quarter 2023 Earnings Release, 2023 Form 10-K Filing and Webcast Conference Call

The Chemours Company (“Chemours” or “the Company”) (NYSE: CC) today announced that the Company currently expects to issue its fourth quarter and full year 2023 financial results and file its Annual Report on Form 10-K for the year ended December 31, 2023 after market close on Wednesday, March 27, 2024.

Read More Press Release

Chemours Announces Appointment of Denise Dignam as President and Chief Executive Officer of the Company

The Chemours Company (“Chemours”) (NYSE: CC), a global chemistry company with leading market positions in Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials, today announced the appointment of Denise Dignam, current Interim Chief Executive Officer, to the positions of President and Chief Executive Officer and a member of the Board of Directors, effective...

Read More Press Release

Chemours and Partners Selected for $60M in U.S. Department of Energy Grants to Support Continued Advancement of Global Hydrogen Economy

Two project grants will support development of next-generation membranes for PEM water electrolysis and developing a circularity infrastructure for clean hydrogen materials The Chemours Company (“Chemours”) (NYSE: CC), a global chemistry company with leading...

Read More Press Release

Chemours Receives NYSE Notice Regarding Delayed Form 10-K Filing

On March 18, 2024, The Chemours Company (“Chemours” or “the Company”) (NYSE: CC) received notice from the New York Stock Exchange (the “NYSE”) that the Company is not in compliance with Section 802.01E of the NYSE Listed Company Manual due to a delay in filing its Annual Report on Form 10-K for the year ended December 31, 2023, with the Securities and Exchange Commission (the “SEC”).

Read More Press Release

Chemours Provides Update on Internal Review

As previously disclosed, the Audit Committee of the Board of Directors of The Chemours Company (“Chemours” or “the Company”) (NYSE: CC), with the assistance of independent outside counsel, has been overseeing an internal review. The review relates to an anonymous report made to the Chemours Ethics Hotline regarding the matters described...

Read More News Article

Actieplan Chemours gericht op moestuinen en zwemwater De Merwelanden

In september kondigde Chemours zijn intentie aan om manieren te zoeken om concrete actie te ondernemen ten behoeve van onze omgeving. Sindsdien zijn we verkennende en constructieve gesprekken aangegaan met de gemeenten Dordrecht, Papendrecht, Sliedrecht en Molenlanden.

Op basis van deze gesprekken ontwikkelt Chemours samen met de gemeenten een plan met concrete acties om de bezorgdheden in de omgeving aan te pakken betreffende het consumeren van voedsel uit moestuinen in de buurt van de Chemours-locatie in Dordrecht, en het nemen van maatregelen met betrekking tot het gebruik van het zwemwater de Merwelanden.

Lees Hier Press Release

Chemours Announces Management Actions and Delay of Form 10-K; Provides Preliminary Unaudited 2023 Year-End Results

Eleventh paragraph, first and second sentences of release dated February 28, 2024 should read: At December 31, 2023, the Company maintained cash and cash equivalents of $1.2 billion; it has restricted cash and restricted cash equivalents of $604 million primarily relating to the U.S.

Read More Press Release

Chemours Announces Management Actions and Delay of Form 10-K; Provides Preliminary Unaudited 2023 Year-End Results

The Board of Directors of The Chemours Company (“Chemours” or “the Company”) (NYSE: CC) has appointed Denise Dignam as the Interim Chief Executive Officer and Matt Abbott as the Interim Chief Financial Officer (principal financial and accounting officer).

Read More Press Release

Chemours Announces Changes to its Board of Directors

Pamela Fletcher appointed as director; Sandra Phillips Rogers will not stand for reelection The Chemours Company (Chemours) (NYSE: CC), a global chemistry company with leading market positions in Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials, today announces two upcoming changes to its Board of Directors.

Read More
Close Filters

Refine Your Results

Brand

Corporate Section

Featured Leader

News Type